Condition
Malignant Digestive System Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Malignant Digestive System Neoplasm clinical trials that are recruiting, at sites in 3 countries (most in United States (7), Guam (1), Puerto Rico (1)). By phase: Phase 2 (2), Phase 1/2 (1). The most active sponsors are M.D. Anderson Cancer Center (3), Mayo Clinic (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 3Countries
Newest Malignant Digestive System Neoplasm clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Vasodilator Therapy to Reduce Vascular Side Effects in GI Cancer Patients on Fluoropyrimidines | Phase 1/2 | Rochester, Minnesota | Recruiting | Mar 9, 2026 |
| Using the PAGODA algorithm to guide FOLFOX dose changes and reduce unplanned chemotherapy delays | — | Fairbanks, Alaska and 397 other locations | Recruiting | Dec 16, 2025 |
| Using fucoidan to prevent fatigue in cancer patients undergoing chemotherapy | Phase 2 | Scottsdale, Arizona | Recruiting | Mar 4, 2025 |
| Understanding risk factors and genetic changes in biliary tree cancers | — | Houston, Texas | Recruiting | Jan 5, 2022 |
| Evaluating portal vein stenting for patients with gastrointestinal cancers and vein narrowing | — | Houston, Texas | Recruiting | Nov 16, 2020 |
| Comparing 2-hour and 6-hour oxaliplatin infusions for gastrointestinal cancer treatment | Phase 2 | Atlanta, Georgia and 2 other locations | Recruiting | Jan 11, 2019 |
| Collecting data on side effects of proton therapy for cancer treatment | — | Houston, Texas | Recruiting | Oct 7, 2009 |
All recruiting trials (7)
-
Vasodilator Therapy to Reduce Vascular Side Effects in GI Cancer Patients on Fluoropyrimidines
This study tests whether vasodilator drugs (isossorbide mononitrate or diltiazem) or placebo can reduce blood vessel toxicity for adults with gastrointestinal cancers treated with fluoropyrimidine chemotherapy.
-
Using the PAGODA algorithm to guide FOLFOX dose changes and reduce unplanned chemotherapy delays
This trial will test whether using the PAGODA algorithm to guide dose changes during FOLFOX chemotherapy for people with gastrointestinal cancers can reduce unplanned treatment delays.
-
Using fucoidan to prevent fatigue in cancer patients undergoing chemotherapy
This study tests if a seaweed supplement called fucoidan can help cancer patients undergoing chemotherapy feel less tired.
-
Understanding risk factors and genetic changes in biliary tree cancers
This study is trying to find out what causes biliary tree cancers and how genetic changes can help doctors understand treatment responses in patients with these cancers.
-
Evaluating portal vein stenting for patients with gastrointestinal cancers and vein narrowing
This study is testing if putting a stent in the portal vein can help people with gastrointestinal cancers and vein narrowing feel better and improve their quality of life.
-
Comparing 2-hour and 6-hour oxaliplatin infusions for gastrointestinal cancer treatment
This study is testing whether giving oxaliplatin over 2 hours instead of 6 hours can help people with gastrointestinal cancer experience less nerve damage while still getting effective treatment.
-
Collecting data on side effects of proton therapy for cancer treatment
This study is trying to learn about the side effects that cancer patients experience after receiving proton therapy to help improve future treatments.
Related topics
Quick answers
How many Malignant Digestive System Neoplasm clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (7 trials), Guam (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.